Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1
The activity of copolymer 1 (Cop 1, Copaxone, glatiramer acetate) in suppressing experimental autoimmune encephalomyelitis (EAE) and in the treatment of multiple sclerosis patients when injected parenterally has been extensively demonstrated. In the present study we addressed the question of whether...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1999
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC22382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10097125/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.96.7.3842 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|